Skip to main content

Nonpsychoactive Cannabinoid Action on 5-HT3 and Glycine Receptors

  • Chapter
  • First Online:
endoCANNABINOIDS

Part of the book series: The Receptors ((REC,volume 24))

Abstract

The 5-HT3 and glycine receptors are pentameric ion channels belonging to a Cys-loop ligand-gated ion channel superfamily. While the glycine receptors can mediate fast inhibitory synaptic transmission, the 5-HT3 receptors are involved in both excitatory and inhibitory synaptic transmission in the central and peripheral nervous system. These receptors play important roles in several physiological and pathological processes such as vomiting reflex, neuromotor activity, pain process, reward mechanism of drugs of abuse, cognition, and anxiety control. Emerging evidence has identified both receptors as primary targets for the action of nonpsychoactive cannabinoids in the brain. Psychoactive and nonpsychoactive cannabinoids alter the amplitudes of 5-hydroxytryptamine and glycine-activated currents in native neurons and in cell lines expressing recombinant 5-HT3 and glycine receptors through CB1 and CB2 receptor-independent mechanisms. However, little is known about molecular mechanisms and behavioral implications of this specific cannabinoid modulation. Results from recent studies have shed light on the molecular basis of nonpsychoactive cannabinoid modulation of glycine receptors. Evidence has also emerged to suggest that cannabinoid modulation of glycine receptors contributes to some of the cannabis-induced analgesic effect. This research direction could help develop novel therapeutic agents for the treatment of pain and other diseases. This chapter summarizes recent research progress in our knowledge about the mechanisms and in vivo consequence of cannabinoid modulation of 5-HT3 and glycine receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

5-HT:

5-Hydroxytryptamine

AEA:

Anandamide

GABA:

γ-Aminobutyric acid

IGly :

Glycine-activated current

THC:

Δ9-Tetrahydrocannabinol

TM:

Transmembrane domain

VTA:

Ventral tegmental area

WT:

Wild type

References

  • Aapro MS, Grunberg SM, Manikhas GM, Olivares G, Suarez T, Tjulandin SA, Bertoli LF, Yunus F, Morrica B, Lordick F, Macciocchi A (2006) A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 17:1441–1449

    Article  PubMed  CAS  Google Scholar 

  • Adermark L, Clarke RB, Olsson T, Hansson E, Soderpalm B, Ericson M (2010) Implications for glycine receptors and astrocytes in ethanol-induced elevation of dopamine levels in the nucleus accumbens. Addict Biol 16:43–54

    Article  Google Scholar 

  • Ahrens J, Demir R, Leuwer M, de la Roche J, Krampfl K, Foadi N, Karst M, Haeseler G (2009a) The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function. Pharmacology 83(4):217–222

    Article  PubMed  CAS  Google Scholar 

  • Ahrens J, Leuwer M, Demir R, Krampfl K, de la Roche J, Foadi N, Karst M, Haeseler G (2009b) Positive allosteric modulatory effects of ajulemic acid at strychnine-sensitive glycine alpha1- and alpha1beta-receptors. Naunyn Schmiedebergs Arch Pharmacol 379(4):371–378

    Article  PubMed  CAS  Google Scholar 

  • Barann M, Molderings G, Bruss M, Bonisch H, Urban BW, Gothert M (2002) Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. Br J Pharmacol 137:589–596

    Article  PubMed  CAS  Google Scholar 

  • Barnes NM, Hales TG, Lummis SC, Peters JA (2009) The 5-HT3 receptor—the relationship between structure and function. Neuropharmacology 56:273–284

    Article  PubMed  CAS  Google Scholar 

  • Becker CM, Hoch W, Betz H (1988) Glycine receptor heterogeneity in rat spinal cord during postnatal development. EMBO J 7:3717–3726

    PubMed  CAS  Google Scholar 

  • Becker CM, Betz H, Schroder H (1993) Expression of inhibitory glycine receptors in postnatal rat cerebral cortex. Brain Res 606:220–226

    Article  PubMed  CAS  Google Scholar 

  • Becker L, von Wegerer J, Schenkel J, Zeilhofer HU, Swandulla D, Weiher H (2002) Disease-specific human glycine receptor alpha1 subunit causes hyperekplexia phenotype and impaired glycine- and GABA(A)-receptor transmission in transgenic mice. J Neurosci 22:2505–2512

    PubMed  CAS  Google Scholar 

  • Betz H, Kuhse J, Schmieden V, Laube B, Kirsch J, Harvey RJ (1999) Structure and functions of inhibitory and excitatory glycine receptors. Ann N Y Acad Sci 868:667–676

    Article  PubMed  CAS  Google Scholar 

  • Bradaia A, Schlichter R, Trouslard J (2004) Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord. J Physiol 559:169–186

    Article  PubMed  CAS  Google Scholar 

  • Brady CA, Dover TJ, Massoura AN, Princivalle AP, Hope AG, Barnes NM (2007) Identification of 5-HT3A and 5-HT3B receptor subunits in human hippocampus. Neuropharmacology 52:1284–1290

    Article  PubMed  CAS  Google Scholar 

  • Butt C, Alptekin A, Shippenberg T, Oz M (2008) Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. J Neurochem 105:1235–1243

    Article  PubMed  CAS  Google Scholar 

  • Chau P, Hoifodt-Lido H, Lof E, Soderpalm B, Ericson M (2009) Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate. Alcohol Clin Exp Res 34:39–45

    Article  PubMed  Google Scholar 

  • Christie MJ, Vaughan CW (2011) Receptors: cannabis medicine without a high. Nat Chem Biol 7:249–250

    Article  PubMed  CAS  Google Scholar 

  • Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF (1999) The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 397:359–363

    Article  PubMed  CAS  Google Scholar 

  • Delaney AJ, Esmaeili A, Sedlak PL, Lynch JW, Sah P (2009) Differential expression of glycine receptor subunits in the rat basolateral and central amygdala. Neurosci Lett 469:237–242

    Article  PubMed  Google Scholar 

  • Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J (1998) Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 12:849–855

    Article  PubMed  CAS  Google Scholar 

  • Demir R, Leuwer M, de la Roche J, Krampfl K, Foadi N, Karst M, Dengler R, Haeseler G, Ahrens J (2009) Modulation of glycine receptor function by the synthetic cannabinoid HU210. Pharmacology 83(5):270–274

    Article  PubMed  CAS  Google Scholar 

  • Eulenburg V, Armsen W, Betz H, Gomeza J (2005) Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci 30:325–333

    Article  PubMed  CAS  Google Scholar 

  • Fan P (1995) Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. J Neurophysiol 73:907–910

    PubMed  CAS  Google Scholar 

  • Fan P, Oz M, Zhang L, Weight FF (1995) Effect of cocaine on the 5-HT3 receptor-mediated ion current in Xenopus oocytes. Brain Res 673:181–184

    Article  PubMed  CAS  Google Scholar 

  • Findlay GS, Wick MJ, Mascia MP, Wallace D, Miller GW, Harris RA, Blednov YA (2002) Transgenic expression of a mutant glycine receptor decreases alcohol sensitivity of mice. J Pharmacol Exp Ther 300:526–534

    Article  PubMed  CAS  Google Scholar 

  • Findlay GS, Phelan R, Roberts MT, Homanics GE, Bergeson SE, Lopreato GF, Mihic SJ, Blednov YA, Harris RA (2003) Glycine receptor knock-in mice and hyperekplexia-like phenotypes: comparisons with the null mutant. J Neurosci 23:8051–8059

    PubMed  CAS  Google Scholar 

  • Findlay GS, Harris RA, Blednov YA (2005) Male transgenic glycine receptor alpha1 (S267Q) mutant mice display a hyperekplexia-like increase in acoustic startle responses. Pharmacol Biochem Behav 82:215–222

    Article  PubMed  CAS  Google Scholar 

  • Foadi N, Leuwer M, Demir R, Dengler R, Buchholz V, de la Roche J, Karst M, Haeseler G, Ahrens J (2010) Lack of positive allosteric modulation of mutated alpha(1)S267I glycine receptors by cannabinoids. Naunyn Schmiedebergs Arch Pharmacol 381(5):477–482

    Article  PubMed  CAS  Google Scholar 

  • Gaddum JH (1953) Tryptamine receptors. J Physiol 119:363–368

    PubMed  CAS  Google Scholar 

  • Godlewski G, Gothert M, Malinowska B (2003) Cannabinoid receptor-independent inhibition by cannabinoid agonists of the peripheral 5-HT3 receptor-mediated von Bezold–Jarisch reflex. Br J Pharmacol 138:767–774

    Article  PubMed  CAS  Google Scholar 

  • Gomeza J, Hulsmann S, Ohno K, Eulenburg V, Szoke K, Richter D, Betz H (2003) Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron 40:785–796

    Article  PubMed  CAS  Google Scholar 

  • Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heindl C, Reinold H, Smart TG, Harvey K, Schutz B, Abo-Salem OM, Zimmer A, Poisbeau P, Welzl H, Wolfer DP, Betz H, Zeilhofer HU, Muller U (2004) GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science 304:884–887

    Article  PubMed  CAS  Google Scholar 

  • Harvey RJ, Topf M, Harvey K, Rees MI (2008) The genetics of hyperekplexia: more than startle! Trends Genet 24:439–447

    Article  PubMed  CAS  Google Scholar 

  • Hejazi N, Zhou C, Oz M, Sun H, Ye JH, Zhang L (2006) {Delta}9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. Mol Pharmacol 69:991–997

    PubMed  CAS  Google Scholar 

  • Herges S, Taylor DA (2000) Involvement of 5-HT(3) receptors in the nucleus accumbens in the potentiation of cocaine-induced behaviours in the rat. Br J Pharmacol 131:1294–1302

    Article  PubMed  CAS  Google Scholar 

  • Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161–202

    Article  PubMed  CAS  Google Scholar 

  • Hu XQ, Peoples RW (2008) The 5-HT3B subunit confers spontaneous channel opening and altered ligand properties of the 5-HT3 receptor. J Biol Chem 283:6826–6831

    Article  PubMed  CAS  Google Scholar 

  • Huestis MA, Cone EJ (2004) Relationship of delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol 28:394–399

    PubMed  CAS  Google Scholar 

  • Jones RH, Holtmann G, Rodrigo L, Ehsanullah RS, Crompton PM, Jacques LA, Mills JG (1999) Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients. Aliment Pharmacol Ther 13:1419–1427

    Article  PubMed  CAS  Google Scholar 

  • Jonsson S, Kerekes N, Hyytia P, Ericson M, Soderpalm B (2009) Glycine receptor expression in the forebrain of male AA/ANA rats. Brain Res 1305(suppl):S27–S36

    Article  PubMed  CAS  Google Scholar 

  • Karnovsky AM, Gotow LF, McKinley DD, Piechan JL, Ruble CL, Mills CJ, Schellin KA, Slightom JL, Fitzgerald LR, Benjamin CW, Roberds SL (2003) A cluster of novel serotonin receptor 3-like genes on human chromosome 3. Gene 319:137–148

    Article  PubMed  CAS  Google Scholar 

  • Koeppe C, Schneider C, Thieme K, Mense S, Stratz T, Muller W, Flor H (2004) The influence of the 5-HT3 receptor antagonist tropisetron on pain in fibromyalgia: a functional magnetic resonance imaging pilot study. Scand J Rheumatol Suppl 119:24–27

    Article  PubMed  CAS  Google Scholar 

  • Li J, Nie H, Bian W, Dave V, Janak PH, Ye JH (2012) Microinjection of glycine into the ventral tegmental area selectively decreases ethanol consumption. J Pharmacol Exp Ther 341(1):196–204

    Article  PubMed  CAS  Google Scholar 

  • Lozovaya N, Yatsenko N, Beketov A, Tsintsadze T, Burnashev N (2005) Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids. J Neurosci 25(33):7499–7506

    Article  PubMed  CAS  Google Scholar 

  • Lozovaya N, Mukhtarov M, Tsintsadze T, Ledent C, Burnashev N, Bregestovski P (2011) Frequency-dependent cannabinoid receptor-independent modulation of glycine receptors by endocannabinoid 2-AG. Front Mol Neurosci 4:13

    Article  PubMed  Google Scholar 

  • Lundeberg L, El-Nour H, Mohabbati S, Morales M, Azmitia E, Nordlind K (2002) Expression of serotonin receptors in allergic contact eczematous human skin. Arch Dermatol Res 294:393–398

    PubMed  CAS  Google Scholar 

  • Lynch JW (2004) Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 84:1051–1095

    Article  PubMed  CAS  Google Scholar 

  • Lynch JW (2009) Native glycine receptor subtypes and their physiological roles. Neuropharmacology 56:303–309

    Article  PubMed  CAS  Google Scholar 

  • Malosio ML, Marqueze-Pouey B, Kuhse J, Betz H (1991) Widespread expression of glycine receptor subunit mRNAs in the adult and developing rat brain. EMBO J 10:2401–2409

    PubMed  CAS  Google Scholar 

  • Manzke T, Niebert M, Koch UR, Caley A, Vogelgesang S, Hulsmann S, Ponimaskin E, Muller U, Smart TG, Harvey RJ, Richter DW (2010) Serotonin receptor 1A-modulated phosphorylation of glycine receptor alpha3 controls breathing in mice. J Clin Invest 120:4118–4128

    Article  PubMed  CAS  Google Scholar 

  • Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D (1991) Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 254:432–437

    Article  PubMed  CAS  Google Scholar 

  • Meyer G, Kirsch J, Betz H, Langosch D (1995) Identification of a gephyrin binding motif on the glycine receptor beta subunit. Neuron 15:563–572

    Article  PubMed  CAS  Google Scholar 

  • Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE, Mascia MP, Valenzuela CF, Hanson KK, Greenblatt EP, Harris RA, Harrison NL (1997) Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 389:385–389

    Article  PubMed  CAS  Google Scholar 

  • Molander A, Soderpalm B (2005a) Accumbal strychnine-sensitive glycine receptors: an access point for ethanol to the brain reward system. Alcohol Clin Exp Res 29:27–37

    Article  PubMed  CAS  Google Scholar 

  • Molander A, Soderpalm B (2005b) Glycine receptors regulate dopamine release in the rat nucleus accumbens. Alcohol Clin Exp Res 29:17–26

    Article  PubMed  CAS  Google Scholar 

  • Morales M, Battenberg E, Bloom FE (1998) Distribution of neurons expressing immunoreactivity for the 5HT3 receptor subtype in the rat brain and spinal cord. J Comp Neurol 402:385–401

    Article  PubMed  CAS  Google Scholar 

  • Morales M, McCollum N, Kirkness EF (2001) 5-HT(3)-receptor subunits A and B are co-expressed in neurons of the dorsal root ganglion. J Comp Neurol 438:163–172

    Article  PubMed  CAS  Google Scholar 

  • Niesler B, Frank B, Kapeller J, Rappold GA (2003) Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 310:101–111

    Article  PubMed  CAS  Google Scholar 

  • Niesler B, Walstab J, Combrink S, Moeller D, Kapeller J, Rietdorf J, Boenisch H, Goethert M, Rappold G, Bruess M (2007) Characterization of the novel human serotonin receptor subunits 5-HT3C, 5- HT3D and 5-HT3E. Mol Pharmacol 72(1):8–17

    Article  PubMed  CAS  Google Scholar 

  • Oz M, Zhang L, Morales M (2002) Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. Synapse 46:150–156

    Article  PubMed  CAS  Google Scholar 

  • Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389–462

    Article  PubMed  CAS  Google Scholar 

  • Przegalinski E, Gothert M, Frankowska M, Filip M (2005) WIN 55,212-2-induced reduction of cocaine hyperlocomotion: possible inhibition of 5-HT(3) receptor function. Eur J Pharmacol 517:68–73

    Article  PubMed  CAS  Google Scholar 

  • Racz I, Bilkei-Gorzo A, Markert A, Stamer F, Gothert M, Zimmer A (2008) Anandamide effects on 5-HT(3) receptors in vivo. Eur J Pharmacol 596:98–101

    Article  PubMed  CAS  Google Scholar 

  • Shiang R, Ryan SG, Zhu YZ, Hahn AF, O’Connell P, Wasmuth JJ (1993) Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet 5:351–358

    Article  PubMed  CAS  Google Scholar 

  • Sigel E, Baur R, Racz I, Marazzi J, Smart TG, Zimmer A, Gertsch J (2011) The major central endocannabinoid directly acts at GABAA receptors. Proc Natl Acad Sci U S A 108:18150–18155

    Article  PubMed  CAS  Google Scholar 

  • Spath M, Stratz T, Farber L, Haus U, Pongratz D (2004a) Treatment of fibromyalgia with tropisetron—dose and efficacy correlations. Scand J Rheumatol Suppl 119:63–66

    Article  PubMed  CAS  Google Scholar 

  • Spath M, Stratz T, Neeck G, Kotter I, Hammel B, Amberger CC, Haus U, Farber L, Pongratz D, Muller W (2004b) Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scand J Rheumatol 33:267–270

    Article  PubMed  CAS  Google Scholar 

  • Spivak CE, Lupica CR, Oz M (2007) The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors. Mol Pharmacol 72:1024–1032

    Article  PubMed  CAS  Google Scholar 

  • Stratz T, Muller W (2004) Treatment of chronic low back pain with tropisetron. Scand J Rheumatol Suppl 119:76–78

    Article  PubMed  CAS  Google Scholar 

  • Thompson AJ, Lummis SC (2007) The 5-HT3 receptor as a therapeutic target. Expert Opin Ther Targets 11:527–540

    Article  PubMed  CAS  Google Scholar 

  • Thompson AJ, Price KL, Lummis SC (2011) Cysteine modification reveals which subunits form the ligand binding site in human heteromeric 5-HT3AB receptors. J Physiol 589:4243–4257

    Article  PubMed  CAS  Google Scholar 

  • van Hooft JA, Yakel JL (2003) 5-HT3 receptors in the CNS: 3B or not 3B? Trends Pharmacol Sci 24:157–160

    Article  PubMed  Google Scholar 

  • Whitehead KJ, Manning JP, Smith CG, Bowery NG (2001) Determination of the extracellular concentration of glycine in the rat spinal cord dorsal horn by quantitative microdialysis. Brain Res 910:192–194

    Article  PubMed  CAS  Google Scholar 

  • Xiong W, Hosoi M, Koo BN, Zhang L (2008) Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. Mol Pharmacol 73:314–322

    Article  PubMed  CAS  Google Scholar 

  • Xiong W, Koo BN, Morton R, Zhang L (2011a) Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism. Neuroscience 184:28–37

    Article  PubMed  CAS  Google Scholar 

  • Xiong W, Cheng K, Cui T, Godlewski G, Rice KC, Xu Y, Zhang L (2011b) Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia. Nat Chem Biol 7(5):296–303

    Article  PubMed  CAS  Google Scholar 

  • Xiong W, Wu X-W, Lovinger MD, Zhang L (2012) A common molecular basis for exogenous and endogenous cannabinoid potentiation of glycine receptors. J Neurosci 32:5200–5208

    Article  PubMed  CAS  Google Scholar 

  • Xu TL, Gong N (2010) Glycine and glycine receptor signaling in hippocampal neurons: diversity, function and regulation. Prog Neurobiol 91:349–361

    Article  PubMed  CAS  Google Scholar 

  • Yang Z, Aubrey KR, Alroy I, Harvey RJ, Vandenberg RJ, Lynch JW (2008) Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. Biochem Pharmacol 76(8):1014–1023

    Article  PubMed  CAS  Google Scholar 

  • Yang KH, Galadari S, Isaev D, Petroianu G, Shippenberg TS, Oz M (2010a) The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes. J Pharmacol Exp Ther 333:547–554

    Article  PubMed  CAS  Google Scholar 

  • Yang KH, Isaev D, Morales M, Petroianu G, Galadari S, Oz M (2010b) The effect of Delta9-tetrahydrocannabinol on 5-HT3 receptors depends on the current density. Neuroscience 171:40–49

    Article  PubMed  CAS  Google Scholar 

  • Yatsenko N, Lozovaya N (2007) Effect of cannabinoids on glycine-activated currents in pyramidal neurons of the rat hippocampus. Neurophysiology 39(1):13

    Article  CAS  Google Scholar 

  • Yevenes GE, Zeilhofer HU (2011) Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoids. PLoS One 6:e23886

    Article  PubMed  CAS  Google Scholar 

  • Yevenes GE, Moraga-Cid G, Peoples RW, Schmalzing G, Aguayo LG (2008) A selective G betagamma-linked intracellular mechanism for modulation of a ligand-gated ion channel by ethanol. Proc Natl Acad Sci U S A 105:20523–20528

    Article  PubMed  CAS  Google Scholar 

  • Yevenes GE, Moraga-Cid G, Avila A, Guzman L, Figueroa M, Peoples RW, Aguayo LG (2010) Molecular requirements for ethanol differential allosteric modulation of glycine receptors based on selective Gbetagamma modulation. J Biol Chem 285:30203–30213

    Article  PubMed  CAS  Google Scholar 

  • Zeilhofer HU, Zeilhofer UB (2008) Spinal dis-inhibition in inflammatory pain. Neurosci Lett 437:170–174

    Article  PubMed  CAS  Google Scholar 

  • Zeilhofer HU, Benke D, Yevenes GE (2012) Chronic pain states: pharmacological strategies to restore diminished inhibitory spinal pain control. Annu Rev Pharmacol Toxicol 52:111–133

    Article  PubMed  CAS  Google Scholar 

  • Zeitz KP, Guy N, Malmberg AB, Dirajlal S, Martin WJ, Sun L, Bonhaus DW, Stucky CL, Julius D, Basbaum AI (2002) The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 22:1010–1019

    PubMed  CAS  Google Scholar 

Download references

Acknowledgement

We thank Dr. David M. Lovinger for critical comments on the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Zhang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Zhang, L., Xiong, W. (2013). Nonpsychoactive Cannabinoid Action on 5-HT3 and Glycine Receptors. In: Abood, M., Sorensen, R., Stella, N. (eds) endoCANNABINOIDS. The Receptors, vol 24. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4669-9_9

Download citation

Publish with us

Policies and ethics